A controversial hire at Arnold Ventures raises questions about the donor’s stance on addiction
A philanthropic giant’s recent hire of a researcher with controversial theories on naloxone access is…
Category: advocacy
Where is PhRMA in the mifepristone debate?
WASHINGTON — A judge’s decision to suspend the Food and Drug Administration’s approval of an…
Opinion: Why genetic testing should always be offered to children with neurodevelopmental differences
At 10 months old, my daughter Gabrielle had missed key milestones for gross motor, fine…
As states ban gender-affirming care, Minnesota aims to be a refuge for trans youth
Across the U.S., lawmakers are pushing for restrictions on transgender youth’s right to gender-affirming care…
Opinion: There is no epidemic of autism. It’s an epidemic of need
On Thursday, the Centers for Disease Control and Prevention announced another increase in the prevalence…
‘It’s a universal experience’: Doctor who treats Boston’s homeless population on why community is vital to health
After 40 years at the helm of nonprofit Boston Health Care for the Homeless Program,…
STAT+: PhRMA chief dings health insurers over drug prices at their own conference
WASHINGTON — The head of the brand drug lobby used an in-person health insurance industry…
‘Leave the chocolate milk out of this’: School cooks, parents, kids push back on USDA effort to make lunches healthier
WASHINGTON — The feds are coming for your kids’ chocolate milk. At least, so says…
Opinion: Ranked to fail: Does gatekeeping affect diversity in The Match?
For graduating medical students hoping to secure a residency training position — and that’s virtually…
Opinion: Clearing the patent thicket: A pathway to faster generic drug approvals
Revelations that AbbVie, the manufacturer of Humira, made more than $100 billion in extra profits…
STAT+: An unlikely new 340B alliance emerges between PhRMA and community health centers
WASHINGTON — An unusual new alliance of the brand-drug lobby PhRMA and community health centers…
Pfizer CEO Albert Bourla maxed out campaign contributions to Dr. Oz ahead of midterm elections
WASHINGTON — Pfizer CEO Albert Bourla made the maximum possible campaign contribution to Mehmet Oz…
Opinion: How cross-state licensure reform can ease America’s mental health crisis
Teletherapy has made mental health care more accessible than ever before, making care possible for…
Opinion: Public health layoffs and tech layoffs: a world of difference
Layoffs in the tech sector — think Google, Amazon, Meta, and the like — from…
Opinion: The FDA is the right agency to regulate CBD products, but it needs help
The dietary supplement industry has been begging for federal oversight of products containing cannabidiol (CBD),…
Opinion: Disruptive science is leaping forward, not limping along
A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that…
Opinion: Unlocking the promise of learning from everyone with cancer
Locked behind the firewalls of proprietary systems sits a treasure trove of data that could…
Opinion: A watershed year for biosimilars — if regulators and policymakers step up
January 31 is set to mark the start of a watershed year for the biosimilars…
Opinion: As it turns 40, the Orphan Drug Act for rare diseases needs a refresh
This month marks the 40th anniversary of the Orphan Drug Act. Since it was signed…
Opinion: How a checklist can help decolonize global health research
When institutions in the United States and other high-income countries embark on collaborations to improve…
Opinion: Making naloxone available over the counter won’t solve the overdose crisis — but it will help
The Food and Drug Administration aims to conduct priority reviews of at least two product…
Opinion: It’s time to retire ‘poor historian’ from clinicians’ vocabularies
Should we pity the “poor historian” — the individual or family member who can’t give…
STAT+: Health groups like AHA, PhRMA channeled millions into end-of-year legislative debates
WASHINGTON — Health care groups and their lobbyists spent big in the last few months…
STAT+: PhRMA terminates lobbying contract with White House official’s brother
WASHINGTON — The pharmaceutical industry lobbying group PhRMA has severed its contract with a lobbyist who…
Make 2023 the year of prioritizing women’s health
Thirty years ago this week, the bill that became the National Institutes of Health Revitalization…
Opinion: The WHO’s new pandemic treaty is good for the world — and the U.S.
In December, delegates from more than 180 countries met in Switzerland to discuss the International…
Opinion: Even with lawsuits and copay caps, will insulin ever be affordable?
In an attempt to tackle the root causes of the inflated cost of insulin, the…
Opinion: Medical school rankings need a new metric: economic mobility index
What are the attributes of a great medical school? U.S. News & World Report’s ranking…
Opinion: Leaders at Davos need to pay attention to the crossroads of climate change, health, and security
As CEOs and world leaders gather for the World Economic Forum in Davos, Switzerland, this…
Opinion: For addiction treatment, longer is better. But insurance companies usually cut it short
Access to treatment for addiction has long plagued U.S. health systems. Why? Two reasons: It…
.jpg)
Opinion: More nurses: The smart way to save lives, money — and nurses
Although the 7,000 New York City nurses who went on strike this week reached a…
Opinion: Democratizing drug development will be a win for all
In 1992, the film Lorenzo’s Oil celebrated the true story of two parents who, despite…
.jpg)
Opinion: Another Ebola outbreak, another missed opportunity for preparedness
When I learned that an outbreak of Ebola was declared in Uganda last fall, I…
Opinion: There are 4 gaps in global pandemic responses. The biggest is missing leadership
Three years after news of the first cases of Covid-19 infections and deaths began to…
Will America’s public health reckoning ever come?
WASHINGTON — After 9/11, Congress created an entirely new government agency to address the threat of…
STAT+: Rep. Jason Smith and the other Republicans leading health policy in the House
Rep. Jason Smith of Missouri will helm the powerful House Ways & Means Committee this…
Opinion: Emergency Medical Treatment and Labor Act is no end-run around abortion bans
The emergency department is often called a hospital’s front door. For many people desperate for…
Opinion: NIH advances landmark recommendations on disability inclusion and anti-ableism
A diverse and inclusive workforce benefits science and research. But unless it includes people living…
Opinion: Allowing pharmacies to dispense methadone is dangerous for patients and communities
Congress is expected to pass a massive $1.7 trillion omnibus spending package that includes numerous…
Opinion: Specialized centers can help realign the U.S.’s moral compass for sickle cell disease
Even as the United States has made commitments to health as a human right and…
Opinion: Reducing the threat of vaccine-preventable diseases starts with kids
Americans have been warned — again — about lax attention to routine vaccinations. This time…
Opinion: The art of the ‘deceased note’: A physician grapples with documenting patients’ final moments
My grandmother died in the hospital, alone, the day after she was “found down” at…
STAT+: AbbVie exits major pharmaceutical industry lobbying groups
WASHINGTON — The maker of one of the world’s most profitable medicines is exiting the…
Opinion: Fixing price instability can improve access to affordable prescription drugs
The high cost of prescription drugs is a very real problem in the United States….
Getting hepatitis C treatment opens new doors for the incarcerated
WARREN, Maine — For the prisoners who receive it, hepatitis C treatment is more than…
Watch: With little more than a typewriter, an Idaho man overturns the entire state’s policy on hepatitis C treatment in prison
BOISE, Idaho — When he took on the state department of corrections, Phil Turney didn’t…
Hundreds of incarcerated people are dying of hep C — even though we have a simple cure
FALLS CITY, Neb. — John Ritchie shouldn’t have died. He knew he had hepatitis C….
Opinion: Paid sick leave is good for workers — and U.S. public health
The fight to expand access to paid sick leave continues even after President Biden decided…
Opinion: Hospice care needs saving
Hospice in America is gravely ill. An extensive investigation jointly published by The New Yorker…
Opinion: Primary care physicians try to give their all — until they can’t. It’s time to flip the archetype to teamwork
My colleague, Skip, was the kind of primary care doctor I always wanted to be….